Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.21B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Mates Sharon | Dec 5, 2024 | Sell | 50,163 | $84.0645 | $4.2M |
| Mates Sharon | Dec 5, 2024 | Sell | 1,534 | $84.6897 | $130,000 |
| Mates Sharon | Dec 4, 2024 | Sell | 27,667 | $85.6222 | $2.4M |
| Mates Sharon | Dec 4, 2024 | Sell | 23,333 | $86.0048 | $2M |
| Halstead Michael | Nov 13, 2024 | Sell | 13,371 | $88.17 | $1.2M |
| Halstead Michael | Nov 13, 2024 | Sell | 5,343 | $88.92 | $480,000 |
| Halstead Michael | Nov 12, 2024 | Sell | 15,105 | $88.72 | $1.3M |
| Halstead Michael | Nov 12, 2024 | Sell | 6,116 | $89.63 | $550,000 |
| Halstead Michael | Nov 12, 2024 | Sell | 1,648 | $90.89 | $150,000 |
| Mates Sharon | Aug 30, 2024 | Sell | 28,203 | $72.732 | $2.1M |
| Mates Sharon | Aug 30, 2024 | Sell | 6,193 | $73.3232 | $450,000 |
| Mates Sharon | Aug 29, 2024 | Sell | 29,832 | $72.4428 | $2.2M |
| Mates Sharon | Aug 29, 2024 | Sell | 5,772 | $73.2451 | $420,000 |
| Mates Sharon | Aug 28, 2024 | Sell | 32,459 | $72.7414 | $2.4M |
| Mates Sharon | Aug 28, 2024 | Sell | 240 | $73.7 | $18,000 |
| Mates Sharon | Aug 27, 2024 | Sell | 23,657 | $73.3341 | $1.7M |
| Mates Sharon | Aug 27, 2024 | Sell | 16,856 | $73.9316 | $1.2M |
| Mates Sharon | Aug 26, 2024 | Sell | 22,713 | $74.5929 | $1.7M |
| Mates Sharon | Aug 23, 2024 | Sell | 28,680 | $74.4573 | $2.1M |
| Mates Sharon | Aug 22, 2024 | Sell | 35,011 | $74.5787 | $2.6M |
| Mates Sharon | Aug 22, 2024 | Sell | 4,369 | $75.4697 | $330,000 |
| Mates Sharon | Aug 21, 2024 | Sell | 44,134 | $75.4026 | $3.3M |
| Mates Sharon | Aug 21, 2024 | Sell | 4,297 | $76.2001 | $330,000 |
| Mates Sharon | Aug 21, 2024 | Sell | 2,682 | $77.2139 | $210,000 |
| Mates Sharon | Aug 21, 2024 | Sell | 1,900 | $77.9805 | $150,000 |
| Neumann Mark | Aug 16, 2024 | Sell | 18,714 | $75.08 | $1.4M |
| RIGGS RORY B | Jun 24, 2024 | Sell | 4,462 | $75.57 | $340,000 |
| VAN NOSTRAND ROBERT L | Jun 18, 2024 | Sell | 11,109 | $76.07 | $850,000 |
| VAN NOSTRAND ROBERT L | Jun 18, 2024 | Sell | 8,891 | $75.71 | $670,000 |
| Mates Sharon | Mar 11, 2024 | Sell | 14,541 | $64.8 | $940,000 |
| Mates Sharon | Mar 11, 2024 | Sell | 4,128 | $65.9 | $270,000 |
| Mates Sharon | Mar 11, 2024 | Sell | 1,590 | $66.81 | $110,000 |
| Hineline Lawrence J. | Mar 11, 2024 | Sell | 4,475 | $66.47 | $300,000 |
| Hineline Lawrence J. | Mar 11, 2024 | Sell | 4,453 | $65.28 | $290,000 |
| Hineline Lawrence J. | Mar 11, 2024 | Sell | 1,100 | $66.54 | $73,000 |
| Halstead Michael | Mar 11, 2024 | Sell | 6,107 | $65.82 | $400,000 |
| Halstead Michael | Mar 11, 2024 | Sell | 1,238 | $66.7 | $83,000 |
| Neumann Mark | Mar 11, 2024 | Sell | 4,303 | $65.11 | $280,000 |
| Neumann Mark | Mar 11, 2024 | Sell | 1,729 | $65.92 | $110,000 |
| Neumann Mark | Mar 11, 2024 | Sell | 1,313 | $66.86 | $88,000 |
| Durgam Suresh K. | Mar 11, 2024 | Sell | 2,179 | $65.06 | $140,000 |
| Mates Sharon | Mar 11, 2024 | Sell | 306 | $67.33 | $21,000 |
| Durgam Suresh K. | Mar 11, 2024 | Sell | 872 | $65.89 | $57,000 |
| Durgam Suresh K. | Mar 11, 2024 | Sell | 661 | $66.96 | $44,000 |
| Hineline Lawrence J. | Mar 11, 2024 | Sell | 64 | $67.12 | $4,300 |
| Hineline Lawrence J. | Mar 11, 2024 | Sell | 29 | $67.32 | $2,000 |
| Mates Sharon | Mar 7, 2024 | Sell | 31,958 | $66.38 | $2.1M |
| Halstead Michael | Mar 7, 2024 | Sell | 12,912 | $66.14 | $850,000 |
| Mates Sharon | Mar 7, 2024 | Sell | 8,754 | $66.93 | $590,000 |
| Hineline Lawrence J. | Mar 7, 2024 | Sell | 6,618 | $66.93 | $440,000 |
| Hineline Lawrence J. | Mar 7, 2024 | Sell | 6,514 | $66.26 | $430,000 |
| Neumann Mark | Mar 7, 2024 | Sell | 8,636 | $66.37 | $570,000 |
| Neumann Mark | Mar 7, 2024 | Sell | 4,496 | $66.95 | $300,000 |
| Durgam Suresh K. | Mar 7, 2024 | Sell | 3,728 | $66.34 | $250,000 |
| Durgam Suresh K. | Mar 7, 2024 | Sell | 2,722 | $66.86 | $180,000 |
| Halstead Michael | Mar 7, 2024 | Sell | 220 | $66.81 | $15,000 |
| VAN NOSTRAND ROBERT L | Feb 27, 2024 | Sell | 10,349 | $73.14 | $760,000 |
| VAN NOSTRAND ROBERT L | Feb 27, 2024 | Sell | 9,651 | $72.71 | $700,000 |
| Mates Sharon | Feb 26, 2024 | Sell | 12,462 | $70.11 | $870,000 |
| MARCUS JOEL S | Feb 26, 2024 | Sell | 17,658 | $69.07 | $1.2M |
| Halstead Michael | Feb 26, 2024 | Sell | 7,215 | $69.54 | $500,000 |
| Hineline Lawrence J. | Feb 26, 2024 | Sell | 6,867 | $69.38 | $480,000 |
| Hineline Lawrence J. | Feb 26, 2024 | Sell | 5,282 | $69.47 | $370,000 |
| Mates Sharon | Feb 26, 2024 | Sell | 9,528 | $69.45 | $660,000 |
| Durgam Suresh K. | Feb 26, 2024 | Sell | 1,400 | $70.16 | $98,000 |
| Durgam Suresh K. | Feb 26, 2024 | Sell | 1,312 | $71.02 | $93,000 |
| Neumann Mark | Feb 26, 2024 | Sell | 4,059 | $69.56 | $280,000 |
| Neumann Mark | Feb 26, 2024 | Sell | 2,341 | $70.7 | $170,000 |
| Neumann Mark | Feb 26, 2024 | Sell | 1,307 | $71.18 | $93,000 |
| MARCUS JOEL S | Feb 26, 2024 | Sell | 8,371 | $67.83 | $570,000 |
| Halstead Michael | Feb 26, 2024 | Sell | 392 | $70.13 | $27,000 |
| Halstead Michael | Feb 26, 2024 | Sell | 300 | $68.54 | $21,000 |
| Hineline Lawrence J. | Feb 26, 2024 | Sell | 600 | $69.81 | $42,000 |
| Hineline Lawrence J. | Feb 26, 2024 | Sell | 300 | $68.33 | $20,000 |
| Hineline Lawrence J. | Feb 26, 2024 | Sell | 288 | $70.15 | $20,000 |
| Mates Sharon | Feb 26, 2024 | Sell | 600 | $68.39 | $41,000 |
| Neumann Mark | Feb 26, 2024 | Sell | 200 | $68.03 | $14,000 |
| MARCUS JOEL S | Feb 26, 2024 | Sell | 299 | $69.6 | $21,000 |
| Halstead Michael | Feb 2, 2024 | Sell | 11,146 | $66.37 | $740,000 |
| Mates Sharon | Feb 2, 2024 | Sell | 17,450 | $67.42 | $1.2M |
| Mates Sharon | Feb 2, 2024 | Sell | 16,435 | $66.7 | $1.1M |
| Hineline Lawrence J. | Feb 2, 2024 | Sell | 10,998 | $66.61 | $730,000 |
| Neumann Mark | Feb 2, 2024 | Sell | 6,904 | $67.49 | $470,000 |
| Neumann Mark | Feb 2, 2024 | Sell | 4,956 | $66.67 | $330,000 |
| Durgam Suresh K. | Feb 2, 2024 | Sell | 3,847 | $67.49 | $260,000 |
| Durgam Suresh K. | Feb 2, 2024 | Sell | 2,320 | $66.69 | $150,000 |
| Halstead Michael | Feb 2, 2024 | Sell | 714 | $67.17 | $48,000 |
| Hineline Lawrence J. | Feb 2, 2024 | Sell | 185 | $67.35 | $12,000 |
| Mates Sharon | Jan 18, 2024 | Sell | 67,597 | $65.19 | $4.4M |
| Mates Sharon | Jan 18, 2024 | Sell | 320 | $66.25 | $21,000 |
| Mates Sharon | Jan 17, 2024 | Sell | 30,633 | $66 | $2M |
| Mates Sharon | Jan 17, 2024 | Sell | 17,451 | $66.66 | $1.2M |
| Mates Sharon | Jan 16, 2024 | Sell | 65,979 | $67.25 | $4.4M |
| Mates Sharon | Jan 16, 2024 | Sell | 5,882 | $67.76 | $400,000 |
| Mates Sharon | Jan 16, 2024 | Sell | 3,500 | $66.38 | $230,000 |
| Halstead Michael | Jan 11, 2024 | Sell | 30,360 | $67.1 | $2M |
| Halstead Michael | Jan 11, 2024 | Sell | 18,154 | $66.31 | $1.2M |
| Halstead Michael | Jan 11, 2024 | Sell | 1,486 | $67.8 | $100,000 |
| Durgam Suresh K. | Jan 2, 2024 | Sell | 37,427 | $70.41 | $2.6M |
| Durgam Suresh K. | Jan 2, 2024 | Sell | 22,645 | $70.8 | $1.6M |
| Durgam Suresh K. | Jan 2, 2024 | Sell | 2,210 | $71.77 | $160,000 |
| Durgam Suresh K. | Dec 13, 2023 | Sell | 21,262 | $65 | $1.4M |
| Halstead Michael | Nov 13, 2023 | Sell | 41,067 | $54.01 | $2.2M |
| Halstead Michael | Nov 13, 2023 | Sell | 8,933 | $53.37 | $480,000 |
| Neumann Mark | Nov 6, 2023 | Sell | 26,754 | $55.9817 | $1.5M |
| Neumann Mark | Nov 6, 2023 | Sell | 15,639 | $55.0174 | $860,000 |
What's the latest insider transaction for Intra-Cellular Therapies?
The most recent insider transaction for Intra-Cellular Therapies was conducted by Mates Sharon, who sold 50,163 shares on December 5, 2024 at a price of $84.06 per share.
Which insider has sold the most ITCI stock over the last two years?
Mates Sharon has sold the most ITCI stock in the last 2 years, with a total value of $51M.
What is the total value of insider transactions for Intra-Cellular Therapies (ITCI) in the last 2 years?
The total value of insider transactions for Intra-Cellular Therapies in the last 2 years is negative, amounting to -$85M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Intra-Cellular Therapies' market confidence?
Over the last 2 years, insider transactions for Intra-Cellular Therapies have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
